Revolutionizing
Bovine Disease
Management

Scalable Platform for Broader Disease Management

Innovative Solutions for Global Health

Tackling infectious diseases in animals and humans caused by LPS (Lipopolysaccharides) from Gram-negative bacteria.

Click Here

Addressing Critical Health Challenges

Click Here

Coliform mastitis, urinary tract infections, sepsis, and enteritis are major concerns.

Combating Antimicrobial Resistance

Tackling infectious diseases in animals and humans caused by LPS (Lipopolysaccharides) from Gram-negative bacteria.

Click Here

Enhancing Immunity

Creating prophylactic vaccines to prevent infections and boost immunity.

Click Here

We're rising to the challenge

Many serious infections go undiagnosed — not because they aren’t there, but because current tests aren’t designed to detect what’s really causing the problem. At Koru Biotech, we’ve uncovered a novel LPS biomarker that’s shifting the focus of diagnostics and opening new possibilities for faster, more effective treatment.

Our solutions

Our innovations are reshaping diagnosis and treatment for mastitis, sepsis, and more.

Explore our solutions

Rapid Diagnostic Kit for Coliform Mastitis

Non-Antibiotic Treatment for Coliform Mastitis

Prophylactic Oral Vaccine for Newborn Calves

StaphGold ELISA Kit

Koru Biotech started by tackling Staph aureus in dairy cows. The result was StaphGold: a practical, accurate tool to detect subclinical mastitis. But during that research, our team made a breakthrough: identifying a novel LPS biomarker linked to a wide range of serious infections. That discovery changed our course — and our purpose.